GT Biopharma
GTBP
GTBP
17 hedge funds and large institutions have $349K invested in GT Biopharma in 2024 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 15 reducing their positions, and 18 closing their positions.
Holders
17
Holders Change
-16
Holders Change %
-48.48%
% of All Funds
0.25%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
15
Closed
18
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Fidelity Investments
Boston,
Massachusetts
|
$271 |
| 2 |
2
BNP Paribas Financial Markets
Paris,
France
|
$27 |
Top Sellers
| 1 |
1
Vanguard Group
Malvern,
Pennsylvania
|
$90.9K |
| 2 |
2
Bank of Montreal
Toronto,
Ontario, Canada
|
$102K |
| 3 |
3
Geode Capital Management
Boston,
Massachusetts
|
$49.8K |
| 4 |
4
BlackRock
New York
|
$44.9K |
| 5 |
5
Wells Fargo
San Francisco,
California
|
$44.4K |
